Dual mode of death induced by etopside in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival

Cancer Research

Volumn 56, Issue 17, 1996, Pages 4006-4012

  Lock, Richard B ^a,b   Stribinskiene, Lolita ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; ETOPOSIDE; GYRASE INHIBITOR; ONCOPROTEIN; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; CELL DEATH; DRUG EFFECT; EPITHELIUM; GENETIC TRANSFECTION; GENETICS; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; EPITHELIUM; ETOPOSIDE; HELA CELLS; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION;

EID: 0029664942     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Belani, C. P., Doyle, L. A., and Aisner, J. Etoposide current status and future perspectives in the management of malignant neoplasms. Cancer Chemother. Pharmacol., 34: S118-S126, 1994
2. Hainsworth, J. D., and Greco, F. A. Etoposide. Twenty years later Ann Oncol., 6: 325-341, 1995.
3. Chen, A Y., and Liu, L. F. DNA lopoisomerases. Essential enzymes and lethal targets Annu. Rev. Pharmacol Toxicol., 34: 191-218, 1994.
4. Lock, R. B , Galperina, O. V., Feldhoff, R. C., and Rhodes, L. J. Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity m HeLa cells Cancer Res., 54: 4933-4939, 1994
5. Kaufmann, S H. Induction of endonucleolytic DNA cleavage m human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5878, 1989
6. Kalwinsky, D. A , Look, A T., Ducore, J., and Fridland, A. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res., 43: 1592-1597, 1983.
7. 2 arrest in Chinese hamster ovary cells. Cancer Res , 50: 3761-3766, 1990
8. Krishan, A., Paika, K., and Frei, E. Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. J. Cell Biol., 66: 521-530, 1975.
9. Singh, B., and Gupta, R S Mutagenic responses of thirteen anticaneer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells. Cancer Res., 43: 577-584, 1983.
10. 2-arrest in Chinese hamster ovary cells treated with anticancer drugs J. Natl. Cancer Inst., 57: 1139-1143, 1976.
11. Berger, N. A., Chatterjee, S., Schmoizer, J. A., and Helms, S. R. Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death. Proc. Natl Acad Sci. USA, 88: 8740-8743, 1991.
12. Shibuya, M. L , Ueno, A. M , Vannais, D. B., Craven, P. A., and Waldren, C. A. Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II Cancer Res., 54: 1092-1097, 1994.
13. cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res., 50 3767-3771, 1990.
14. Kerr, J F. R., Winterford, C M , and Harmon, B V. Apoptosis. Its significance in cancer and cancer therapy Cancer (Phila.), 73: 2013-2026, 1994.
15. Thompson, C. B Apoptosis in the pathogenesis and treatment of disease Science (Washington DC), 267: 1456-1462, 1995.
16. Hickman, J A Apoptosis induced by anticancer drugs. Cancer Metastasis Rev , 11: 121-139, 1992
17. Tounekti, O., Pron, G., Belehradek, J., Jr., and Mir, L. M. Bleomycin, an apoptosismimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res , 53: 5462-5469, 1993
18. Rodilla, V. Origin and evolution of binucleated cells and binucleated cells with micronuclei in cisplalin-treated CHO cultures Mutat. Res., 300: 281-291, 1993.
19. Chang, W. P., and Little, J B. Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Am J Radiat Biol., 60: 483-496, 1991
20. Lau, C. C., and Pardee, A. B. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad Sci USA, 79: 2942-2946, 1982
21. Demarcq, C., Bunch, R T , Creswell, D., and Eastman, A The role of cell cycle progression in cisplatm-induced apoptosis in Chinese hamster ovary cells. Cell Growth & Differ., 5: 983-993, 1994.
22. Chan, V T W., Ng, S., Eder, J P., and Schnipper, L. E Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line J Biol Chem., 268: 2160-2165, 1993.
23. Hsiung, Y., Jannatipour, M., Rose, A., McMahon, J., Duncan, D , and Nitiss, J. L. Functional expression of human topoisomerase IIα in yeast mutations at amino acids 450 or 803 of topoisomerase IIα result in enzymes than can confer resistance to anti-topoisomerase II agents. Cancer Res., 56: 91-99, 1996
24. Harker, W. G., Slade, D. L , Drake, F H , and Parr, R. L Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II β isoform. Biochemistry, 30: 9953-9961, 1991.
25. r 160,000 topoisomerase IIα is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line Cancer Res., 55: 2129-2134, 1995.
26. Webb, C. D , Latham, M D., Lock, R. B., and Sullivan, D. M Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line Cancer Res., 51: 6543-6549, 1991.
27. Cole, S. P C., Sparks, K. E., Fraser, K , Loe, D W., Grant, C. E , Wilson, G M , and Deeley, R. G Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells Cancer Res , 54: 5902-5910, 1994.
28. Sullivan, D M., and Ross, W. E. Resistance to inhibitors of DNA topoisomerases In. R. F. Ozols (ed), Molecular and Clinical Advances in Anticancer Drug Resistance, pp. 57-99. Boston: Kluwer Academic Publishers, 1991.
29. Lowe, S W , Bodis, S , McClatchey, A , Remington, L., Ruley, H E., Fisher, D. E , Housman, D E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
30. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993
31. Lovve, S. W., Ruley, H. E., Jacks, T , and Housman, D. E p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74 957-967, 1993.
32. Strasser, A., Harris, A. W., Jacks, T., and Gory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 Cell. 79: 329-339, 1994.
33. Hockenbery, D , Nunez, G., Milliman, C , Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
34. Krajewski, S., Tanaka, S., Takayama, S , Schibler, M J., Fenton, W., and Reed, J. C Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondnal membranes. Cancer Res., 53: 4701-4714, 1993.
35. Dole, M., Nunez, G , Merchant, A. K , Maybaum, J , Rode, C. K., Bloch, C. A , and Castle, V P. Bcl-2 inhibits chemotherapy-induced apoptusis in neuroblastoma. Cancer Res., 54: 3253-3259, 1994
36. Kamesaki, S., Kamesaki, H., Jorgensen, T. J , Tanizawa, A., Pommier, Y , and Coasman. J. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res , 53: 4251-4256, 1993.
37. Reed, J. C BCL-2: prevention of apoptosis as a mechanism of drug resistance Hematol Oncol. Clin N. Am., 9: 451-473, 1995.
38. Hellemans, P., Vandam, P. A., Weyler, J , Vanoosterom, A. T., Buytaert, P., and Vanmarck, E. Prognostic value of bcl-2 expression in invasive breast cancer. Br J. Cancer. 72: 354-360, 1995
39. Gasparmi, G , Barbareschi, M., Dogliont, C., Palma, P D , Mauri, F. A., Boracchi, P., Bevilacqua, P., Cafto, O , Morelli, L , Verderio, P., Pezzella, F., and Harris, A L. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin. Cancer Res., 1: 189-198, 1995.
40. cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etopobide. Cancer Res., 52: 1817-1822, 1992.
41. cdc2/cyclin-B kinase m relation to cell cycle perturbations induced by etoposide. Int. J Oncol , 3 33-42, 1993
42. Herrmann, M., Lorenz, H-M., Voll, R , Grunke, M , Woith, W., and Kalden, J R A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res , 22: 5506-5507, 1994
43. Teixeira, C , Reed, J. C., and Pratt, M. A C. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res , 55: 3902-3907, 1995.
44. Yin, D. X. and Schimke, R. T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res , 55 4922-4928, 1995
45. Anderson, R. D., and Berger, N A. Mutagenicity and carcinogenicity of topoisomerase-interactive agents Mutat. Res., 309: 109-142, 1994.
46. Agarwal, K., Muhkerjee, A , and Sen, S. Etoposide (VP-16): cytogenetic studies in mice. Environ. Mol. Mutagen., 23: 190-193, 1994.
47. Hashimoto, H , Chatterjee, S., and Berger, N. A. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression Cancer Res., 55: 4029-4035, 1995
48. Lasorella, A., Iavarone, A., and Israel, M. A. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance Cancer Res., 55: 4711-4716, 1995.
49. Oberhammer, F , Wilson, J W , Dive, C , Morris, I. D , Hickman, J. A , Wakeling, A E , Walker, P R , and Sikorska, M. Apoptolic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of intemucleosonul fragmentation. EMBO J., 12: 3679-3684, 1993.